Thus, we studied the expression of FXR in hilar cholangiocarcinoma and whether its role in hilar cholangiocarcinoma was enhanced or decreased, and we investigated whether FXR inhibitors have an effect on its expression in tumour tissues. This evidence concerns the gene NR1H4 and neoplasm.